Back to all studies
UnknownNCT04307875

Hypertension and Diabetes Assessment in the Rohingya Refugee Population and in the Host Communities in Bangladesh

This study has public registry information. It focuses on PTSD and currently lists study information.

PTSD, Depression, ...Diagnostic TestOver 18 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT04307875. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether Blood pressure measurement (sphygmomanometer) may be useful for adults experiencing ptsd.

What would participation involve?

Participants may complete study activities around Blood pressure measurement (sphygmomanometer), complete questionnaires or follow-up assessments, provide blood samples or biological tests.

Who is it mainly for?

This study appears to be mainly for adults with ptsd.

What should you check before joining?

Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateEstimated: October 1, 2021
Recruitment status
Unknown
Estimated enrollment
3,000
Sponsor
University Hospital Freiburg
Sponsor type
Hospital / academic medical center
Study type
Diagnostic Test
Intervention type
DIAGNOSTIC_TEST, OTHER
Study phase
Not clearly listed
Locations
Not clearly listed
Age range
Over 18 Years
Official registry ID
NCT04307875
Official title
Hypertension and Diabetes Mellitus Assessment in the Rohingya Refugee Population and in the Host Communities in Bangladesh
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT04307875. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help clarify how this condition is measured or understood.

It requires regular follow-up, often through questionnaires or interviews.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

Based on the public registry summary, this study is trying to understand: Due to a massive outbreak of violence against the Rohingya minority residing in the Rakhine State of Myanmar in late 2017, several hundred thousand Rohingya fled the country and sought a shelter in Bangladesh. Currently, in the refugee settlement areas east of the city of Cox's. The study team can confirm the exact objective and what it means for you.

Does this study involve biological samples, imaging, or biomarkers?

This appears to be a biological / biomarker / imaging study involving Blood pressure measurement (sphygmomanometer), Blood glucose measurement, psychometric tests. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Who might this study be for?

This study may concern people with ptsd; age range: Over 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to provide biological samples, complete lab tests, or take part in imaging or measurement procedures.

What should I check about samples, imaging, data, and possible discomfort?

If the study involves samples, imaging, or biomarkers, ask what is collected, how it is stored, who can access results, whether there may be discomfort, and whether results are shared with you. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

What practical constraints should I expect?

The likely practical burden appears high. Things to check include multiple visits or assessments, questionnaires/interviews/assessments, biological/imaging measurements. Ask the study team about duration, visits, possible compensation, data access, and what happens if you want to stop.

Who is behind this study?

This study is sponsored by University Hospital Freiburg, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The recruitment status is not clearly listed. Check the official registry or contact the study team. The registry lists an estimated enrollment of 3,000 participants.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me